Haoxinqing closes RMB125m Series A, 2019 revenue near RMB300m

Haoxinqing (“good mood”) has officially completed a Series A financing round, raising 125 million yuan. KIP, the company’s Pre-A round lead investor also participated in this around.

Haoxinqing (“good mood”) has officially completed a Series A financing round, raising 125 million yuan. KIP, the company’s Pre-A round lead investor also participated in this around.

Founded in 2016, Haoxinqing focuses on the central nervous system. It mainly utilizes intelligent diagnosis and treatment systems as well as online hospital service systems to provide rehabilitation management and online consultation service for patients with mental and psychological diseases.

Chen Guanwei, founder and CEO of Haoxinqing, said: “The latest funding round has seen support and approval by new and existing investors. All funds are in place and will be used to continue to expand the business volume, ramp up the research and development and investment of intelligent diagnosis and treatment systems, and recruit talents.

At present, there are more than 27,000 registered psychiatrists and neurologists on the Haoxinqing online medical platform, accounting for about 70% of the total number of doctors in this field. The platform has more than three million registered users and an average monthly active number of more than 100,000 users. The company’s revenue in 2019 is close to 300 million yuan.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/05/30/haoxinqing-closes-rmb125m-series-a-2019-revenue-near-rmb300m/.

Leave a Reply

Please Login to Comment